Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy

被引:1
|
作者
Kong, Vickie C. [1 ,2 ]
Dang, Jennifer [1 ]
Li, Winnie [1 ,2 ]
Navarro, Inmaculada [1 ,2 ]
Padayachee, Jerusha [1 ,2 ]
Malkov, Victor [1 ,2 ]
Winter, Jeff [1 ,2 ]
Raman, Srinivas [1 ,2 ]
Berlin, Alejandro [1 ,2 ]
Catton, Charles [1 ,2 ]
Warde, Padraig [1 ,2 ]
Chung, Peter [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
关键词
MR -guided adaptive radiotherapy; IMRT; VMAT; Prostate SBRT; VOLUMETRIC MODULATED ARC; BODY RADIOTHERAPY; PLAN QUALITY; CANCER; THERAPY; BRACHYTHERAPY;
D O I
10.1016/j.tipsro.2022.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: To compare the dosimetry of prostate stereotactic radiotherapy (SBRT) delivered by adaptive intensity modulated radiotherapy (A-IMRT) and 3 degree of freedom volumetric modulated arc therapy (3DOF VMAT) Methods & Materials: Twenty-five prostate patients treated with High Dose Rate (HDR) brachytherapy followed by SBRT were included (fifteen with hydrogel spacer in place for treatment). Interfraction changes in the volume of prostate, rectum and bladder were measured. Fractional dose to these structures was estimated for A-IMRT and 3DOF-VMAT for comparison against the corresponding reference dose and between each other. Results: Clinically acceptable dose was delivered to prostate in all 125 fractions through A-IMRT and 3DOFVMAT. A-IMRT was better than 3DOF-VMAT in reducing dose to 1 cm3 of rectum. Conversely, 3DOF-VMAT was superior in sparing 50% and 20% of rectum. When comparing the reference and delivered dose, there was no significant difference for Bladder D5cm3 for either technique. However, rectum in the high dose region benefited more from A-IMRT by being irradiated to a lower than reference dose in more fractions than 3DOFVMAT. Hydrogel spacer reduced the rectal dose and was associated with a smaller deviation from reference dose for rectum D50% for A-IMRT. Conclusions: Despite the presence of large interfraction organ volumes changes, clinically acceptable dose was delivered to the prostate by both systems. A-IMRT facilitated a greater rectal sparing from the high dose region than 3DOF-VMAT. Further reduction in rectal dose could be achieved by hydrogel spacer to displace the rectum, or by adaptation delivered by VMAT.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [21] Tumor control after MR-guided adaptive stereotactic radiotherapy for adrenal metastases
    Schneiders, F.
    Van Vliet, C.
    Palacios, M. A.
    Slotman, B. J.
    Lagerwaard, F. J.
    Bruynzeel, A. M.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S35 - S36
  • [22] Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
    Padgett, Kyle R.
    Simpson, Garrett N.
    Llorente, Ricardo
    Samuels, Michael A.
    Dogan, Nesrin
    CUREUS, 2018, 10 (04):
  • [23] MR-guided adaptive stereotactic ablative body radiotherapy (MRgSABR) in thoracic tumours
    Moreno-Olmedo, Elena
    George, Ben
    Woolf, David
    Conibear, John
    Gaya, Andy
    Owczarczyk, Kasia
    Aznar, Luis
    Adams, Joss
    Ezhil, Veni
    Sevitt, Timothy
    Dickinson, Peter
    Franks, Kevin
    Martin, Alex
    Camilleri, Philip
    Good, James
    Hiley, Crispin
    LUNG CANCER, 2024, 190
  • [24] Stereotactic radiotherapy and MR-guided adaptive techniques for locally advanced pancreatic cancer
    Ermongkonchai, T.
    Khor, R.
    Muralidharan, V.
    Tebbutt, N.
    Lim, K.
    Kutaiba, N.
    Ng, S. P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1001 - S1002
  • [25] Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers
    Padgett, Kyle R.
    Simpson, Garrett
    Asher, David
    Portelance, Lorraine
    Bossart, Elizabeth
    Dogan, Nesrin
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2020, 77 : 54 - 63
  • [26] Feasibility of online adaptive MR-guided stereotactic Radiotherapy for Patients with Pancreatic Cancer
    von Bestenbostel, R.
    Rogowski, P.
    Nierer, L.
    Straub, K.
    Niyazi, M.
    Belka, C.
    Corradini, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S41 - S42
  • [27] A Simple Adaptive Planning Workflow for MR-Guided Radiotherapy of Prostate Cancer
    Chen, X.
    Paulson, E.
    Ahunbay, E.
    Omari, E.
    Hall, W.
    Lawton, C.
    Straza, M.
    Li, X.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [28] Analysis of rectal dose during prostate stereotactic body radiotherapy in MR-guided radiotherapy.
    Sritharan, Kobika
    Dunlop, Alex
    Mitchell, Adam
    Mohajer, Jonathan
    Smith, Gillian
    Tree, Alison
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [29] Automated Treatment Planning for adaptive MR-guided Radiotherapy of Prostate Cancer
    Tengler, B.
    Hagmueller, M.
    Kuenzel, L. A.
    Nachbar, M.
    Moennich, D.
    Boeke, S.
    Gani, C.
    Zips, D.
    Thorwarth, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S17 - S17
  • [30] Feasibility of neurovascular sparing MR-guided adaptive radiotherapy for prostate cancer
    Teunissen, F.
    Wortel, R.
    Hes, J.
    Willigenburg, T.
    de Boer, J.
    Meijer, R.
    van Melick, H.
    Verkooijen, H.
    van Zyp, J. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1126 - S1127